Plant sterol levels during cholesterol-lowering therapy

Plant sterol levels during cholesterol-lowering therapy - Plant sterol levels during cholesterol-lowering therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003346

Enrollment

100

Registered

2010-03-17

Start date

2008-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cornary Heart Dsease with Hyperlipidemia

Interventions

Statin high dose mono therapy Statin+Ezetimibe combination therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cornary Heart Dsease with Hyperlipidemia patient who fills following criteria nonHDL Cholesterol 130mg/dL or more 20 years or more

Exclusion criteria

Exclusion criteria: Hypersenstivity Patient who has received it within four weeks undertaking administering of medicine Resin/Fibrate/Niacin/EPA/ Probucol etc Patient who judged that examination doctor in charge is improper

Design outcomes

Primary

Measure	Time frame
serum lipid levels inflammatory markers choresterol synthesis/absoption markers	—

Secondary

Measure	Time frame
Clinical laboratory test results Adverse events	—

Countries

Japan

Contacts

Public ContactKouji Kajinami

Kanazawa Medical University Department of Cardiology

kajinami@kanazawa-med.ac.jp076-286-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026